35 Gatehouse Drive A-2
Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies. Drawing on discoveries made in the lab of Scientific Founder Tim Springer, Morphic was created in 2015 with co-founders Polaris Partners, T.A. Springer and Schrödinger, Inc., along with ShangPharma Investment Group.
CEO: Praveen Tipirneni, M.D.
Chief Development Officer: Alex Lugovskoy, Ph.D.
Vice President of Chemistry: Blaise Lippa, Ph.D.
Vice President of Finance and Operations: Robert Farrell, CPA